Approval is granted based on preliminary clinical data and results in a provisional (not standard and full) registration, time limited to 2 years, with an option for two further two-year extensions, to a total of 6 years
Peripherally, they reduce insulin resistance, slow gastric emptying and promote weight loss, which is beneficial for T2D but potentially problematic in PD [12, 13]
From the very first interaction, the level of professionalism, attention to detail, and warmth toward people stood out in a way that's hard to put into words, but impossible to ignore
Not for use in humans or animals
Variants in GLP1R (the GLP-1 receptor itself), GIPR (the GIP receptor particularly relevant for tirzepatide), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide